Literature DB >> 24760593

Feasibility of SaeboFlex upper-limb training in acute stroke rehabilitation: a clinical case series.

Rebecca A Stuck1, Lisa M Marshall, Ramachandran Sivakumar.   

Abstract

Upper-limb (UL) recovery following stroke is often poor. UL rehabilitation therefore continues to be a major focus for occupational therapy. Published evidence for the effectiveness of SaeboFlex training in acute stroke rehabilitation is scarce. The purpose of this study is to explore the feasibility and patient experience of SaeboFlex training in acute stroke. This feasibility study recruited stroke patients (< 84 days post-stroke) with moderate/severe UL weakness. They participated in SaeboFlex sessions for 12 weeks in addition to conventional rehabilitation. A battery of measures was taken at baseline, 4, 8 and 12 weeks. Eight participants were recruited. For the action research arm test score and UL Motricity Index, clinically significant improvements were noted in five out of seven (71%) and six out of seven participants (86%) respectively. Clinically significant improvements were also noted in secondary outcomes. Shoulder complications occurred in one participant. SaeboFlex training facilitated clinically significant improvements in UL function. It has the potential to improve participation and independence in ADLs, reduce carer burden and associated costs. Being a feasibility study with no control arm, we urge caution in interpreting these results. Future research is needed to evaluate the efficacy, optimum dosage and impact on dependency levels of SaeboFlex training as part of a randomized controlled trial.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  SaeboFlex; stroke rehabilitation; upper limb

Mesh:

Year:  2014        PMID: 24760593     DOI: 10.1002/oti.1369

Source DB:  PubMed          Journal:  Occup Ther Int        ISSN: 0966-7903            Impact factor:   1.448


  1 in total

1.  Patient and Therapist Experiences of the SaeboFlex: A Pilot Study.

Authors:  Larissa Andriske; Debbie Verikios; Danielle Hitch
Journal:  Occup Ther Int       Date:  2017-01-09       Impact factor: 1.448

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.